Ticker LaunchReverse merger · Completed · SLRX
Salarius Pharmaceuticals, LLC
Reverse merger with Flex Pharma, Inc.
Salarius Pharmaceuticals, LLC merged into Flex Pharma, Inc., a Nasdaq-listed pharma company, in a reverse merger that takes the private company public. The deal was announced on Jan 3, 2019 and closed on Jul 19, 2019. The combined company trades as Salarius Pharmaceuticals, Inc. (SLRX) on Nasdaq.
Salarius Pharmaceuticals is a clinical-stage oncology company targeting the epigenetic regulation of cancer, with a lead candidate in clinical trials for Ewing sarcoma. It became Nasdaq-listed through its merger with Flex Pharma.
- Status
- Completed
- Private company
- Salarius Pharmaceuticals, LLC
- Public company
- Flex Pharma, Inc.
- Public company business before
- Nasdaq-listed pharma company
- Announced
- Jan 3, 2019
- Closed
- Jul 19, 2019
- Combined company
- Salarius Pharmaceuticals, Inc. (SLRX)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Announcement press release
- Closing 8-K Jul 22, 2019
- Closing press release
- All filings on EDGAR CIK 1615219
Other completed reverse mergers
- Stabilis Energy LLCinto American Electric Technologies, Inc. · Jul 26, 2019
- Patagonia Gold Plcinto Hunt Mining Corp. · Jul 22, 2019
- Emmaus Life Sciences, Inc.into MYnd Analytics, Inc. · Jul 17, 2019
- Hire Quest Holdings, LLCinto Command Center, Inc. · Jul 15, 2019
- Jin Wan Hong (BVI) International Holdings Limitedinto Jin Wan Hong International Holdings Limited · Jul 15, 2019
- NeuBase Therapeutics, Inc.into Ohr Pharmaceutical, Inc. · Jul 12, 2019